Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions
Introduction: Although pharmacogenetics and pharmacogenomics have been at the forefront of research aimed at finding novel personalized therapies, the focus of research has recently extended to the potential of intestinal microbiota to affect drug efficacy. Complex interplay of gut microbiota with b...
Saved in:
Main Authors: | Maja Đanić (Author), Nebojša Pavlović (Author), Slavica Lazarević (Author), Bojan Stanimirov (Author), Saša Vukmirović (Author), Hani Al-Salami (Author), Armin Mooranian (Author), Momir Mikov (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
by: Momir Mikov, et al.
Published: (2023) -
Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model
by: Maja Ðanić, et al.
Published: (2019) -
Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
by: Slavica Lazarević, et al.
Published: (2022) -
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites
by: Maja Đanić, et al.
Published: (2024) -
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Maja Ðanić, et al.
Published: (2018)